Polo-like kinase-1 Inhibitors and the Antiandrogen Abiraterone Synergistically Disrupt Mitosis and Kill Cancer Cells of Disparate Origin Independently of Androgen Receptor Signaling

Jesse C. Patterson(Massachusetts Institute of Technology), Michael B. Yaffe(Massachusetts Institute of Technology)
bioRxiv (Cold Spring Harbor Laboratory)
May 13, 2022
Cited by 0


Related Papers